News

JAN2026 NEW PARTNERSHIP

Launching a Multi-regional Managed Access Program, Expanding Access to Revuforj® (revumenib) Outside the U.S. in Partnership with Syndax Pharmaceuticals

WODA and Syndax Pharmaceuticals partner to expand access to Revuforj® (revumenib) via a Managed Access Program in Eurasia, Europe, Israel, Middle East, Turkey, Latin America, and Africa.

MAR2024 CERTIFICATE OF RECOGNITION

WODA is the winner of the 2023 Go Global Awards in the category of Collaborative Industry Partnership!

We are overjoyed with this remarkable achievement, especially since it is rigorously judged by a panel of international business experts.

SEP2024 IMPROVING AVAILABILITY OF ORPHAN DRUGS IN SAUDI ARABIA

Saudi Food and Drug Authority New Guidance for Orphan Drugs

The Saudi Food and Drug Authority has recently issued new guidelines for orphan drug designation, with a positive impact on companies and patients.

SEP2024 NEW WODA MEMBER FOR AUSTRALIA, NEW ZEALAND AND SOUTHEAST ASIA

World Orphan Drug Alliance Welcomes Specialised Therapeutics

Specialised Therapeutics to represent WODA in Australia, New Zealand and across Southeast Asia (ANZSEA)

SEP2024 DISTRIBUTION AGREEMENT TO INTRODUCE PKU GOLIKE® IN THE MIDDLE EAST

Vector Pharma and Relief Therapeutics Ink Exclusive Distribution Agreement to Introduce PKU GOLIKE® in the Middle East

NOV2023 THREE NEW WODA ALLIANCE MEMBERS – RARESTONE, CTS AND PATH PHARMA

World Orphan Drug Alliance expands its global reach with three new members

World Orphan Drug Alliance (WODA) welcomes RareStone Group, CTS and Path Pharma as new alliance partners.

JAN2024 WODA DISTRIBUTION AGREEMENT WITH THERATECHNOLOGIES FOR EGRIFTA SV™

Theratechnologies Enters into Distribution Agreement with WODA for EGRIFTA SV™

Theratechnologies announced a multi-year distribution agreement with WODA for the commercialisation of EGRIFTA SV™ (tesamorelin).

JAN2024 PARTNERING WITH DECISIVE CONSULTING WILL BROADEN WODA ALLIANCE'S ACCESS CAPABILITY

WODA Alliance Partners with Decisive Consulting to Strengthen Market Access Capabilities

Decisive Consulting to support WODA with strategic advice and operational hands-on support for Market Access.

JUN2024 WODA ALLIANCE IS REACHING PATIENTS WITH RARE DISEASES ACROSS THE GLOBE

World Orphan Drug Alliance (WODA): Reaching patients with rare diseases across the globe

WODA offers a “one-stop-shop” for biotech and pharma companies seeking to commercialize orphan drugs in these regions.